Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cells.
Maulana TI, Teufel C, Cipriano M, Roosz J, Lazarevski L, van den Hil FE, Scheller L, Orlova V, Koch A, Hudecek M, Alb M, Loskill P. Maulana TI, et al. Among authors: hudecek m. Cell Stem Cell. 2024 Jul 5;31(7):989-1002.e9. doi: 10.1016/j.stem.2024.04.018. Epub 2024 May 15. Cell Stem Cell. 2024. PMID: 38754430 Free article.
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.
Turtle CJ, Hanafi LA, Berger C, Hudecek M, Pender B, Robinson E, Hawkins R, Chaney C, Cherian S, Chen X, Soma L, Wood B, Li D, Heimfeld S, Riddell SR, Maloney DG. Turtle CJ, et al. Among authors: hudecek m. Sci Transl Med. 2016 Sep 7;8(355):355ra116. doi: 10.1126/scitranslmed.aaf8621. Sci Transl Med. 2016. PMID: 27605551 Free PMC article. Clinical Trial.
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple Myeloma.
Munawar U, Zhou X, Prommersberger S, Nerreter S, Vogt C, Steinhardt MJ, Truger M, Mersi J, Teufel E, Han S, Haertle L, Banholzer N, Eiring P, Danhof S, Navarro-Aguadero MA, Fernandez-Martin A, Ortiz-Ruiz A, Barrio S, Gallardo M, Valeri A, Castellano E, Raab P, Rudert M, Haferlach C, Sauer M, Hudecek M, Martinez-Lopez J, Waldschmidt J, Einsele H, Rasche L, Kortüm KM. Munawar U, et al. Among authors: hudecek m. Commun Biol. 2023 Dec 21;6(1):1299. doi: 10.1038/s42003-023-05683-4. Commun Biol. 2023. PMID: 38129580 Free PMC article.
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies.
Einsele H, Briones J, Ciceri F, García-Cadenas I, Falkenburg F, Bolaños N, Heemskerk HMM, Houot R, Hudecek M, Locatelli F, Morgan K, Morris CE, O'Dwyer M, Gil JS, van den Brink M, van de Loosdrecht AA. Einsele H, et al. Among authors: hudecek m. Hemasphere. 2020 Jun 29;4(4):e423. doi: 10.1097/HS9.0000000000000423. eCollection 2020 Aug. Hemasphere. 2020. PMID: 32904089 Free PMC article. No abstract available.
A highly soluble Sleeping Beauty transposase improves control of gene insertion.
Querques I, Mades A, Zuliani C, Miskey C, Alb M, Grueso E, Machwirth M, Rausch T, Einsele H, Ivics Z, Hudecek M, Barabas O. Querques I, et al. Among authors: hudecek m. Nat Biotechnol. 2019 Dec;37(12):1502-1512. doi: 10.1038/s41587-019-0291-z. Epub 2019 Nov 4. Nat Biotechnol. 2019. PMID: 31685959 Free PMC article.
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy.
Maulana TI, Kromidas E, Wallstabe L, Cipriano M, Alb M, Zaupa C, Hudecek M, Fogal B, Loskill P. Maulana TI, et al. Among authors: hudecek m. Adv Drug Deliv Rev. 2021 Jun;173:281-305. doi: 10.1016/j.addr.2021.03.015. Epub 2021 Mar 30. Adv Drug Deliv Rev. 2021. PMID: 33798643 Free article. Review.
128 results